Ad
related to: nci dictionary cancer personality test
Search results
Results from the WOW.Com Content Network
A woman accessing the PDQ database with an early laptop in 1987. Physician Data Query (PDQ) is the US National Cancer Institute's (NCI) comprehensive cancer database. [1] [2] It contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care, and complementary and alternative medicine; a registry of more than 6,000 open and 17,000 closed cancer ...
The test is done after the tumor cells are removed from the body. A chemosensitivity assay may help in choosing the best drug or drugs for the cancer being treated. With dozens of chemotherapy agents and hundreds of combinations available for treatment, oncologists often select a regimen from standard protocols developed in clinical trials.
An early wooden sign for the National Cancer Institute Members of the first National Advisory Cancer Council at the groundbreaking ceremonies of the NCI's building 6 in Bethesda, Maryland (June 1938) August 5, 1937: President Franklin D. Roosevelt signed into law the National Cancer Institute Act (Pub.
All articles transcluding this template are automatically included in Category:Wikipedia articles incorporating text from the National Cancer Institute Dictionary of Cancer Terms The above documentation is transcluded from Template:NCI-cancer-dict/doc .
People with a "cancer personality"—depressed, repressed, self-loathing and afraid to express their emotions—were believed to have manifested cancer through subconscious desire. Some psychotherapists claimed that treatment to change the patient's outlook on life would cure the cancer. [239]
The Common Terminology Criteria for Adverse Events (CTCAE), [1] formerly called the Common Toxicity Criteria (CTC or NCI-CTC), are a set of criteria for the standardized classification of adverse events of drugs and treatment used in cancer therapy. The CTCAE system is a product of the US National Cancer Institute (NCI).
The National Cancer Institute (NCI), in particular, defines biomarker as a: “A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.
Chemosensitizer entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain material from Dictionary of Cancer Terms . U.S. National Cancer Institute .
Ad
related to: nci dictionary cancer personality test